Boston Scientific
Medical Devices and Equipment and Supplies
Multinational United States Est. 1979
Team
3
201-500 employees
Confidence
59/100
News
17
articles
About
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies.
Classification
Tags
medical-devicesmanufacturing
News (17)
Apr 22, 2026 · finance.yahoo.com
US stocks rally toward a record while Brent oil tops $100 on uncertainty about the Iran war
Dec 23, 2025 · finance.yahoo.com
growth-positive
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
Customers
Dec 11, 2025 · en.globes.co.il
growth-negative
The transfer from Yokne'am to Galway will be completed by 2028. Galil Medical employs about 100 people.
LayoffsAcquisition
Dec 1, 2025 · finance.yahoo.com
growth-positive
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Sep 18, 2025 · finance.yahoo.com
growth-positive
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Product StagePartners
Sep 9, 2025 · finance.yahoo.com
growth-positive
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
Product StageFDA approved/pending approval
Aug 22, 2025 · finance.yahoo.com
growth-positive
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
InvestmentPartnersProduct Stage
Aug 21, 2025 · finance.yahoo.com
growth-positive
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
Product StageFDA approved/pending approval
Jul 24, 2025 · finance.yahoo.com
growth-positive
Stocks making big moves yesterday: Power Integrations, Booz Allen Hamilton, Wendy's, SentinelOne, and Boston Scientific
Jul 22, 2025 · finance.yahoo.com
growth-positive
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
Management Changes
Jun 24, 2025 · finance.yahoo.com
growth-positive
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?
Product Stage
Jun 17, 2025 · finance.yahoo.com
growth-negative
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
Product StageCustomers
Mar 4, 2025 · en.globes.co.il
growth-positive
The US medical device company will pay up to $540 million for the Rehovot-based intravascular ultrasound device developer for treating high blood pressure.
Acquisition
Mar 3, 2025 · www.calcalistech.com
growth-positive
The acquisition adds a promising alternative to traditional blood pressure medications.
Acquisition
Mar 3, 2021 · en.globes.co.il
growth-positive
Boston Scientific to buy Lumenis surgical division for $1.1b
AcquisitionExpand
Oct 23, 2018 · www.calcalistech.com
growth-positive
Boston Scientific Signed a Distribution Deal with Israeli Allium Medical
Partners
Oct 10, 2012 · en.globes.co.il
growth-positive
Israeli investors profit from Boston Scientific's Rythmia acquisition - Globes
Acquired-by
Details
Employees
201-500
Exact Count
351
Founded
1979
Crunchbase
boston-scientific
Locations
HaKidma St 6, Yokne'am Illit, Israel
Marlborough, MA, USA
Links
Admin
Last Update
Apr 22, 2026
Verified by
Maor Perlov
Missing
product stage, sector, tags, business model, video or image, funding rounds, markets, not claimed
Team (3)
Dudi Reznick
Director, Head of Urology R&D
Carmit Yaron-Lehmann
Head of HR Boston Scientific Israel
Jonathan Goldstein
Director, Innovation Strategy and Venture
Internal
Created by
Maor Perlov (maor.perlov@sncentral.org)
Created
2023-07-31T00:00:00.000Z
Last editor
Maor Perlov (maor.perlov@sncentral.org)
Status
Public on NYSE on May, 1992;
Recent activity
Maor Perlov · Manual · 2023-08-02 06:03:13.000000
Maor Perlov · Manual · 2023-08-02 06:03:13.000000
Maor Perlov · Manual · 2023-08-02 06:01:43.000000
Eran Levin · Automatic · 2024-12-22 06:38:48.000000
Maor Perlov · Manual · 2023-08-02 05:56:19.000000
Maor Perlov · Manual · 2023-07-31 12:00:48.000000
Maor Perlov · Manual · 2023-08-02 05:54:38.000000
Maor Perlov · Manual · 2024-10-21 11:22:31.000000
Maor Perlov · Manual · 2023-08-02 05:53:55.000000
Maor Perlov · Manual · 2023-08-02 05:53:47.000000